HIF-1alpha regulates hypoxia-induced EP1 expression in osteoblastic cells

Area of Science:

• Bone Biology
• Cellular Physiology
• Molecular Mechanisms

Background:

• Oxygen tension changes during skeletal development and fracture influence bone cell activity.
• Hypoxia-inducible factor-1alpha (HIF-1alpha) is a key transcription factor activated by low oxygen, regulating cellular adaptation and survival.
• Previous work indicated hypoxic osteoblasts increase prostaglandin E2 (PGE2) and EP1 receptor expression.

Purpose of the Study:

• To investigate the role of HIF-1alpha in regulating EP1 receptor expression in osteoblasts.
• To determine if HIF-1alpha directly influences EP1 expression under hypoxic conditions.
• To explore the involvement of SAPK/JNK signaling in this process.

Main Methods:

• Osteoblastic cells were treated with dimethyloxaloglycine (DMOG) or PHD2 siRNA to stabilize HIF-1alpha.
• HIF-1alpha function was assessed using siRNA targeting HIF-1alpha prior to hypoxia exposure.
• EP1 expression and hypoxia-responsive element (HRE) activation were measured.
• SAPK/JNK activity was inhibited to evaluate its impact on EP1 expression.

Main Results:

• Stabilizing HIF-1alpha (using DMOG or PHD2 siRNA) increased EP1 expression in normoxic cells.
• HIF-1alpha siRNA treatment attenuated hypoxia-induced HRE activation and reduced EP1 expression.
• Inhibition of SAPK/JNK signaling decreased hypoxia-induced EP1 expression without affecting HIF-1alpha levels.
• These findings implicate HIF-1alpha as a direct regulator of EP1 expression.

Conclusions:

• HIF-1alpha plays a critical role in mediating hypoxia-induced EP1 expression in osteoblasts.
• This mechanism is important for understanding how HIF-1alpha influences bone development and fracture repair.
• The SAPK/JNK pathway is involved in regulating EP1 expression downstream of HIF-1alpha activation.